Global mRNA Treatment Market Size, Share & Trends Analysis Report By Product Type (Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs), By Therapeutic Area, By Route of Administration, By Region, And Segment Forecasts, 2023-2031

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global mRNA Treatment Market Snapshot

Chapter 4. Global mRNA Treatment Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Clinical Trial/Pipeline Analysis

4.7. COVID 19 Impact Analysis on Healthcare Industry

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Product Type:

5.2.1. Prophylactic vaccines

5.2.2. Therapeutic vaccines

5.2.3. Therapeutic drugs

Chapter 6. Market Segmentation 2: Therapeutic Area Estimates & Trend Analysis

6.1. Therapeutic Area & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Therapeutic Area:

6.2.1. Infectious Diseases

6.2.2. Oncological Disorders

6.2.3. Other Disorders

Chapter 7. Market Segmentation 3: Route of Administration Estimates & Trend Analysis

7.1. Route of Administration & Market Share, 2019 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following Route of Administration:

7.2.1. Intravenous

7.2.2. Intramuscular

7.2.3. Intranasal

7.2.4. Others

Chapter 8. mRNA Treatment Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Product Type, 2020-2030

8.1.2. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Therapeutic Area, 2020-2030

8.1.3. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Route of Administration, 2020-2030

8.1.4. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe mRNA Treatment Market revenue (US$ Million) by Product Type, 2020-2030

8.2.2. Europe mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.2.3. Europe mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.2.4. Europe mRNA Treatment Market revenue (US$ Million) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Product Type, 2020-2030

8.3.2. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.3.3. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.3.4. Asia Pacific mRNA Treatment Market revenue (US$ Million) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America mRNA Treatment Market revenue (US$ Million) by Product Type, (US$ Million)

8.4.2. Latin America mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2020-2030

8.4.3. Latin America mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2020-2030

8.4.4. Latin America mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Product Type, (US$ Million)

8.5.2. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, (US$ Million)

8.5.3. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Route of Administration (US$ Million)

8.5.4. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. CureVac

9.2.2. Moderna

9.2.3. BioNTech (Pfizer)

9.2.4. Translate Bio(Sanofi)

9.2.5. Ethris (AstraZeneca)

9.2.6. Kernal Biologics

9.2.7. Silence Therapeutics

9.2.8. eTheRNA (Etherna Immunotherapies)

9.2.9. Tiba Biotechnology

9.2.10. In-Cell-Art

9.2.11. Anima Biotech

9.2.12. H3 Biomedicine Inc.

9.2.13. Arcturus Therapeutics

9.2.14. eFFECTOR Therapeutics, Inc.

9.2.15. Ionis Pharmaceuticals, Inc.

9.2.16. Stemirna Therapeutics Co., Ltd.

9.2.17. Skyhawk Therapeutics, Inc.

9.2.18. RNAimmune (Sirnaomics)

9.2.19. Ziphius Therapeutics NV

9.2.20. miRagen Therapeutics, Inc.

9.2.21. GlaxoSmithKline plc

9.2.22. Other Prominent Players

Global mRNA Treatment Market Segmentation:

Global mRNA Treatment Market Revenue (US$ Mn) by Product Type

• Prophylactic vaccines
• Therapeutic vaccines
• Therapeutic drugs

Global mRNA Treatment Market Revenue (US$ Mn) Based on Therapeutic Area

• Infectious Diseases
• Oncological Disorders
• Other Disorders

Global mRNA Treatment Market Revenue (US$ Mn) Based on Route of Administration

• Intravenous
• Intramuscular
• Intranasal
• Others

Global mRNA Treatment Market Revenue (US$ Mn) Based on Region

Europe mRNA Treatment Market Revenue (US$ Mn) by Country

• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

North America mRNA Treatment Market Revenue (US$ Mn) by Country

• U.S.
• Canada

Asia Pacific mRNA Treatment Market Revenue (US$ Mn) by Country

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America mRNA Treatment Market Revenue (US$ Mn) by Country

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa mRNA Treatment Market Revenue (US$ Mn) by Country

• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.